166 related articles for article (PubMed ID: 28791453)
1. [The Paris system for classification of urinary cytology].
Savic S; Vlajnic T; Bubendorf L
Pathologe; 2017 Sep; 38(5):451-462. PubMed ID: 28791453
[TBL] [Abstract][Full Text] [Related]
2. [Cytology of the urinary tract: Between uncertainty and clarity].
Bubendorf L; Dalquen P; Savic S
Pathologe; 2009 Dec; 30 Suppl 2():173-8. PubMed ID: 19820939
[TBL] [Abstract][Full Text] [Related]
3. Urinary cytology and the Paris system for reporting urinary cytology: Implications for urological management.
Gupta M; VandenBussche CJ; Bivalacqua TJ
Cytopathology; 2018 Aug; 29(4):368-370. PubMed ID: 29575439
[TBL] [Abstract][Full Text] [Related]
4. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
5. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology.
Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR
Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848
[TBL] [Abstract][Full Text] [Related]
6. The effects of the current World Health Organization/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results.
Curry JL; Wojcik EM
Cancer; 2002 Jun; 96(3):140-5. PubMed ID: 12115301
[TBL] [Abstract][Full Text] [Related]
7. Urinary cytology in the detection of bladder tumours. Influence of concomitant urothelial atypia.
Harving N; Petersen SE; Melsen F; Wolf H
Scand J Urol Nephrol Suppl; 1989; 125():127-31. PubMed ID: 2633311
[TBL] [Abstract][Full Text] [Related]
8. Fluorescent in situ hybridization as a predictor of relapse in urothelial carcinoma.
García-Peláez B; Trias I; Román R; Pubill C; Banús JM; Puig X
Actas Urol Esp; 2013; 37(7):395-400. PubMed ID: 23453297
[TBL] [Abstract][Full Text] [Related]
9. [The value of exfoliative cytology of the urine in the diagnosis of bladder tumors].
Maier U; Kuber W; Krepler R
Onkologie; 1980 Dec; 3(6):276-77. PubMed ID: 7012724
[TBL] [Abstract][Full Text] [Related]
10. [Urinary cytology. Possibilities, limitations and the future].
Zaak D; Tritschler S; Knuechel R; Vom Dorp F; Hakenberg OW; Hautmann S; Rübben H
Urologe A; 2006 Sep; 45 Suppl 4():97-101. PubMed ID: 16821054
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of voided urine and bladder barbotage cytology in detecting transitional cell carcinoma of the urinary tract.
Konety BR; Metro MJ; Melham MF; Salup RR
Urol Int; 1999; 62(1):26-30. PubMed ID: 10436427
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the Cytomorphological Features in Atypical Urine Specimens following Application of The Paris System for Reporting Urinary Cytology.
Glass R; Rosen L; Chau K; Sheikh-Fayyaz S; Farmer P; Coutsouvelis C; Slim F; Brenkert R; Das K; Raab S; Cocker R
Acta Cytol; 2018; 62(1):54-61. PubMed ID: 29151086
[TBL] [Abstract][Full Text] [Related]
13. [What is the value of urine cytology in after-care of patients with urothelial cancers?].
Möllhoff S; Rathert P
Urologe A; 1992 Jul; 31(4):203-5. PubMed ID: 1514198
[No Abstract] [Full Text] [Related]
14. [Possibilities for the use of exfoliative urine cytology in invasive and noninvasive bladder cancer].
Stadie G; Ebert W; Müller H
Z Urol Nephrol; 1985 Jun; 78(6):331-7. PubMed ID: 4036385
[TBL] [Abstract][Full Text] [Related]
15. UroVysion® multiprobe FISH in the triage of equivocal urinary cytology cases.
Bubendorf L; Piaton E
Ann Pathol; 2012 Dec; 32(6):e52-6, 438-43. PubMed ID: 23244486
[TBL] [Abstract][Full Text] [Related]
16. Implementing The Paris System for Reporting Urinary Cytology results in a decrease in the rate of the "atypical" category and an increase in its prediction of subsequent high-grade urothelial carcinoma.
Wang Y; Auger M; Kanber Y; Caglar D; Brimo F
Cancer Cytopathol; 2018 Mar; 126(3):207-214. PubMed ID: 29278461
[TBL] [Abstract][Full Text] [Related]
17. Voided urine versus bladder washing cytology for detection of urothelial carcinoma: which is better?
Keller AK; Jensen JB
Scand J Urol; 2017 Aug; 51(4):290-292. PubMed ID: 28398114
[TBL] [Abstract][Full Text] [Related]
18. Application of The Paris System to atypical urine cytology samples: correlation with histology and UroVysion
Miki Y; Neat M; Chandra A
Cytopathology; 2017 Apr; 28(2):88-95. PubMed ID: 27601215
[TBL] [Abstract][Full Text] [Related]
19. Cytokeratin 20 immunocytochemistry on urine sediments: A potential low-cost adjunct to cytology in the diagnosis of low-grade urothelial carcinoma.
Wadhwa N; Diwaker P; Lotha N; Arora VK; Singh N
Cytopathology; 2017 Dec; 28(6):531-535. PubMed ID: 28940433
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of perioperative methylene blue-stained and permanent Papanicolaou-stained urine cytology to detect patients with high-grade urothelial cancer or the urinary bladder. Part 1].
Rossi R; Jaeger T; Börgermann C; Furtkamp C; Moos Stahl R; Rübben H; vom Dorp F
Urologe A; 2007 Sep; 46(9):1145-7. PubMed ID: 17661004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
